Ovation Science Inc. Grants Stock Options

Ovation Science (CSE OVAT)
Published on: March 20, 2020

Vancouver, BC – March 20, 2020 (CSE: OVAT) – Ovation Science Inc. (“Ovation” or the “Company”) is pleased to announce that on March 20, 2020, the Company granted 470,000 stock options to directors and officers of the Company. The stock options are exercisable at $0.40 per share for a period of two years from the date of grant.

About Ovation Science Inc.

Ovation Science Inc. is a company that licenses its proprietary topical and transdermal cannabis formulations made with its patented Invisicare® skin delivery technology. Invisicare, used in Ovation’s topical and transdermal products, enhances the delivery of cannabidiol (CBD) and tetrahydrocannabinol (THC) to and through the skin.

www.ovationscience.com

Forward-Looking Statements Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Ovation Science Inc. cautions that all forward looking statements are inherently uncertain and that actual results may be affected by a number of material factors, many of which are beyond Ovation Science Inc.’s control.

Neither Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Contact:

FOR INVESTOR RELATIONS:

Doug Kerr

[email protected]

Phone (604) 315.4400

FOR BUSINESS DEVELOPMENT & CORPORATE INQUIRIES:

Doreen McMorran

[email protected]

Phone: (604) 283.0903 ext. 4

Biotechnology Coronavirus COVID-19 Healthcare Services